chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Cerebral atrophy, Chest X-ray abnormal, Computerised tomogram head abnormal, Cough, Dizziness
Clinical narrative: Patient is fully vaccinated.  Tested Positive for COVID on admission to hospital. This patient was admitted through the emergency room because COVID-19 pneumonia and hypoxia. The patient presented to the hospital with chief complaint of progressive shortness of breath and cough.  The patient not checked her O2 saturation at home and was about 86%. blood . tests showed creatinine of 1.34. Lung perfusion scan showed multiple large wedge-shaped perfusion defect in the left upper pulmonary lobe.  Venous Doppler lower extremity bilateral, no evidence of DVT. CXR: mild pulmonary congestion. The patient was put on oxygen titration, she did fairly well to 2 L nasal cannula.  The patient was put on steroids in addition to anticoagulation. Remdesivir given. D-dimer elevated.  Acute pulmonary embolism, started on Lovenox treatment, on therapeutic dose, continue monitoring oxygen therapy. Pt discharged 1/14/2022 and then readmitted on 1/14/2022. Pt daughter states pt discharged from hospital today. Pt daughter states pt had episode of dizziness, jerked back on toilet and not responding. Questionable seizure. Troponin now elevated. Cr 1.44. Hg 9.9.  discharged 1/26 . Ativan as needed for breakthrough seizure . CT scan:1. No acute intracranial abnormality. 2. Senescent changes including cerebral volume loss and sequelae of chronic microangiopathy. 3. If there is sufficient clinical concern for acute ischemia, further evaluation with brain MRI is recommended. 1/17 CXR progressive b/l pulmonary infiltrate. IV antibiotics.   Discharged.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Dyskinesia, Dyspnoea, Fibrin D dimer increased, Haemoglobin decreased, Hypoxia
Clinical narrative: Patient is fully vaccinated.  Tested Positive for COVID on admission to hospital. This patient was admitted through the emergency room because COVID-19 pneumonia and hypoxia. The patient presented to the hospital with chief complaint of progressive shortness of breath and cough.  The patient not checked her O2 saturation at home and was about 86%. blood . tests showed creatinine of 1.34. Lung perfusion scan showed multiple large wedge-shaped perfusion defect in the left upper pulmonary lobe.  Venous Doppler lower extremity bilateral, no evidence of DVT. CXR: mild pulmonary congestion. The patient was put on oxygen titration, she did fairly well to 2 L nasal cannula.  The patient was put on steroids in addition to anticoagulation. Remdesivir given. D-dimer elevated.  Acute pulmonary embolism, started on Lovenox treatment, on therapeutic dose, continue monitoring oxygen therapy. Pt discharged 1/14/2022 and then readmitted on 1/14/2022. Pt daughter states pt discharged from hospital today. Pt daughter states pt had episode of dizziness, jerked back on toilet and not responding. Questionable seizure. Troponin now elevated. Cr 1.44. Hg 9.9.  discharged 1/26 . Ativan as needed for breakthrough seizure . CT scan:1. No acute intracranial abnormality. 2. Senescent changes including cerebral volume loss and sequelae of chronic microangiopathy. 3. If there is sufficient clinical concern for acute ischemia, further evaluation with brain MRI is recommended. 1/17 CXR progressive b/l pulmonary infiltrate. IV antibiotics.   Discharged.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Lung disorder, Lung infiltration, Microangiopathy, Pulmonary congestion, Pulmonary embolism
Clinical narrative: Patient is fully vaccinated.  Tested Positive for COVID on admission to hospital. This patient was admitted through the emergency room because COVID-19 pneumonia and hypoxia. The patient presented to the hospital with chief complaint of progressive shortness of breath and cough.  The patient not checked her O2 saturation at home and was about 86%. blood . tests showed creatinine of 1.34. Lung perfusion scan showed multiple large wedge-shaped perfusion defect in the left upper pulmonary lobe.  Venous Doppler lower extremity bilateral, no evidence of DVT. CXR: mild pulmonary congestion. The patient was put on oxygen titration, she did fairly well to 2 L nasal cannula.  The patient was put on steroids in addition to anticoagulation. Remdesivir given. D-dimer elevated.  Acute pulmonary embolism, started on Lovenox treatment, on therapeutic dose, continue monitoring oxygen therapy. Pt discharged 1/14/2022 and then readmitted on 1/14/2022. Pt daughter states pt discharged from hospital today. Pt daughter states pt had episode of dizziness, jerked back on toilet and not responding. Questionable seizure. Troponin now elevated. Cr 1.44. Hg 9.9.  discharged 1/26 . Ativan as needed for breakthrough seizure . CT scan:1. No acute intracranial abnormality. 2. Senescent changes including cerebral volume loss and sequelae of chronic microangiopathy. 3. If there is sufficient clinical concern for acute ischemia, further evaluation with brain MRI is recommended. 1/17 CXR progressive b/l pulmonary infiltrate. IV antibiotics.   Discharged.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Seizure, Troponin increased, Ultrasound Doppler normal, Unresponsive to stimuli
Clinical narrative: Patient is fully vaccinated.  Tested Positive for COVID on admission to hospital. This patient was admitted through the emergency room because COVID-19 pneumonia and hypoxia. The patient presented to the hospital with chief complaint of progressive shortness of breath and cough.  The patient not checked her O2 saturation at home and was about 86%. blood . tests showed creatinine of 1.34. Lung perfusion scan showed multiple large wedge-shaped perfusion defect in the left upper pulmonary lobe.  Venous Doppler lower extremity bilateral, no evidence of DVT. CXR: mild pulmonary congestion. The patient was put on oxygen titration, she did fairly well to 2 L nasal cannula.  The patient was put on steroids in addition to anticoagulation. Remdesivir given. D-dimer elevated.  Acute pulmonary embolism, started on Lovenox treatment, on therapeutic dose, continue monitoring oxygen therapy. Pt discharged 1/14/2022 and then readmitted on 1/14/2022. Pt daughter states pt discharged from hospital today. Pt daughter states pt had episode of dizziness, jerked back on toilet and not responding. Questionable seizure. Troponin now elevated. Cr 1.44. Hg 9.9.  discharged 1/26 . Ativan as needed for breakthrough seizure . CT scan:1. No acute intracranial abnormality. 2. Senescent changes including cerebral volume loss and sequelae of chronic microangiopathy. 3. If there is sufficient clinical concern for acute ischemia, further evaluation with brain MRI is recommended. 1/17 CXR progressive b/l pulmonary infiltrate. IV antibiotics.   Discharged.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Ventilation/perfusion scan abnormal
Clinical narrative: Patient is fully vaccinated.  Tested Positive for COVID on admission to hospital. This patient was admitted through the emergency room because COVID-19 pneumonia and hypoxia. The patient presented to the hospital with chief complaint of progressive shortness of breath and cough.  The patient not checked her O2 saturation at home and was about 86%. blood . tests showed creatinine of 1.34. Lung perfusion scan showed multiple large wedge-shaped perfusion defect in the left upper pulmonary lobe.  Venous Doppler lower extremity bilateral, no evidence of DVT. CXR: mild pulmonary congestion. The patient was put on oxygen titration, she did fairly well to 2 L nasal cannula.  The patient was put on steroids in addition to anticoagulation. Remdesivir given. D-dimer elevated.  Acute pulmonary embolism, started on Lovenox treatment, on therapeutic dose, continue monitoring oxygen therapy. Pt discharged 1/14/2022 and then readmitted on 1/14/2022. Pt daughter states pt discharged from hospital today. Pt daughter states pt had episode of dizziness, jerked back on toilet and not responding. Questionable seizure. Troponin now elevated. Cr 1.44. Hg 9.9.  discharged 1/26 . Ativan as needed for breakthrough seizure . CT scan:1. No acute intracranial abnormality. 2. Senescent changes including cerebral volume loss and sequelae of chronic microangiopathy. 3. If there is sufficient clinical concern for acute ischemia, further evaluation with brain MRI is recommended. 1/17 CXR progressive b/l pulmonary infiltrate. IV antibiotics.   Discharged.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2, Mechanical urticaria, Urticaria
Clinical narrative: ~2 weeks following my 3rd moderna shot I developed migratory urticarial rash (no angioedema or difficulty breathing). There is definite dermatographism (have photos from different time periods since then). With H2 antagosist (loratadine, certrizine) this controls it but for the first 2ms I was taking this q24h. I went to my internist to make certain I did not have CML. He and DR (virtual consult) agreed that this was likely post-vaccination related and continue with H2 antagonists. I still have the hives 4ms later (although less frequent - taking  Loratadine or certrizine only ~3x/ week now).  I am a pediatric Infectious Disease doctor and am constantly exposed to Covid when on service in the hospital so I may be getting natural boosting repeatedly over the past months. Good news is that everyone in my household got COVID but I did not so I probably have a high titer with all thee Hives :)
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, General physical condition abnormal, Rales, Tachycardia
Clinical narrative: toxic appearing, tachycardia, rales, weakness
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient was administered 0.5ml instead of 0.25ml, patient was called on1/19/2022 and denies any problems since vaccination. Letter was sent to patient informing of dosage given
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Clinician prepared vial with 1.3ml Normal Saline diluent rather than 1.8ml Normal Saline. No Clinical concerns were reported
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site mass, Injection site pain, Mobility decreased, Pain
Clinical narrative: After initial soreness, redness, and small lump around injection site in upper left arm, I am unable to lift my arm past a 45 degree angle. It is extremely painful to lift my arm to be level with my shoulder, and then there's pain down to my elbow to lift my arm above my head. There was not a reaction like this to the first two shots, and I had no other reactions in the three shots other than this. Two months later, I still cannot lift anything with my left arm.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: After initial soreness, redness, and small lump around injection site in upper left arm, I am unable to lift my arm past a 45 degree angle. It is extremely painful to lift my arm to be level with my shoulder, and then there's pain down to my elbow to lift my arm above my head. There was not a reaction like this to the first two shots, and I had no other reactions in the three shots other than this. Two months later, I still cannot lift anything with my left arm.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Cellulitis, Chills, Erythema, Injection site erythema, Injection site pain
Clinical narrative: expected post vaccine symptoms - fever, chills and aches and pain at injection site, all symptoms resolved x24hrs except arm pain  1/28 s/p Vax +4d, left arm felt tight, hot and very painful, was also swollen and red, full range of motion and pulses + but very painful and hot, throughout the day the redness was spreading down the upper arm to the lower portion
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Injection site warmth, Joint range of motion decreased, Limb discomfort, Pain in extremity
Clinical narrative: expected post vaccine symptoms - fever, chills and aches and pain at injection site, all symptoms resolved x24hrs except arm pain  1/28 s/p Vax +4d, left arm felt tight, hot and very painful, was also swollen and red, full range of motion and pulses + but very painful and hot, throughout the day the redness was spreading down the upper arm to the lower portion
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pyrexia, Skin warm
Clinical narrative: expected post vaccine symptoms - fever, chills and aches and pain at injection site, all symptoms resolved x24hrs except arm pain  1/28 s/p Vax +4d, left arm felt tight, hot and very painful, was also swollen and red, full range of motion and pulses + but very painful and hot, throughout the day the redness was spreading down the upper arm to the lower portion
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Deep vein thrombosis, Magnetic resonance imaging, Pulmonary pain
Clinical narrative: Deep vein thrombosis, legs blood clots, lungs pain, back in Hospital 10/31-11/2. Recovered on Eliquis for 6 months.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Asthenia, COVID-19, Headache
Clinical narrative: In the evening almost at night time I was feeling weak, body pains, and I had a headache. The next morning on 11/27 I got an at home Covid test and then a PCR test and both came back positive. I lost my smell and taste a couple of days later. I was taking some Tylenol. They told me to rest and drink a lot of fluids. I recovered in 5 days.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, SARS-CoV-2 test positive
Clinical narrative: In the evening almost at night time I was feeling weak, body pains, and I had a headache. The next morning on 11/27 I got an at home Covid test and then a PCR test and both came back positive. I lost my smell and taste a couple of days later. I was taking some Tylenol. They told me to rest and drink a lot of fluids. I recovered in 5 days.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product preparation issue
Clinical narrative: Clinician prepared vial with 1.3ml Normal Saline diluent rather than 1.8ml Normal Saline. No Clinical concerns were reported
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Erythema, Rash, Urticaria
Clinical narrative: 9 days after receiving my booster shot I began getting a rash with hives that began at night starting with my head and then would go away and reappear in other spots.  When scratching the hives it would get worse and spread even more and leave red marks for about 30 minutes after scratching and then go away. I took Claritin and Benadryl with no ease of symptoms.  It was pretty severe for weeks, when I finally saw my doctor and she prescribed Prednisone Steroid. This helped some while I was on it but came back soon after doses were done.  I started taking Zyrtec and a lot of Zinc, vitamin C and D, and that would help to ease the hives as long as I was on it, so I kept taking that for about a week but cut back the Zyrtec to only once a week because I don't like staying on medication like that. I'm on week 11 now, still trying to take a lot of Zinc, C, and D, and I do not take the Zyrtec anymore.  I still get small, less intense hives everyday usually in the evenings and at night. I recently (12 days ago) have been infected with the Covid virus, and hives have stayed about the same while sick.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram, Epistaxis, Headache, Hypertension, Impaired work ability
Clinical narrative: I noticed that after receiving the vaccine, I started getting migraines daily. They have become so severe that my blood pressure was at level 1 hypertension. My menstrual cycles were significantly worse. Consistent headaches that lasted for weeks. I went to urgent care due to a nose bleed that would not stop due to my elevated blood pressure. I still suffer from headaches a year later. I have never had sever headaches like these. Its ongoing like daily. I do cocktails of OTC meds and I was prescribed Sumatriptan. This helps with the issue but the issue is unresolved. My work is affected but my supervisor is aware of the situation and makes accommodations when the headaches are to much to handle. Urgent care took vitals and completed a CAT scan. I was given some medication via IV.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Menstrual disorder, Migraine
Clinical narrative: I noticed that after receiving the vaccine, I started getting migraines daily. They have become so severe that my blood pressure was at level 1 hypertension. My menstrual cycles were significantly worse. Consistent headaches that lasted for weeks. I went to urgent care due to a nose bleed that would not stop due to my elevated blood pressure. I still suffer from headaches a year later. I have never had sever headaches like these. Its ongoing like daily. I do cocktails of OTC meds and I was prescribed Sumatriptan. This helps with the issue but the issue is unresolved. My work is affected but my supervisor is aware of the situation and makes accommodations when the headaches are to much to handle. Urgent care took vitals and completed a CAT scan. I was given some medication via IV.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Injection site pain
Clinical narrative: Patient was administered 0.5ml instead of0.25ml of booster 3rd dosage, patient called on 1/19/2022 and denies problems except for sore shoulder at injection site after vaccination. Letter sent to patient informing of dosage given
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test normal, Electrocardiogram normal, Hypertension
Clinical narrative: Sudden, sustained high blood pressure. First measurement was 175/93 on 1/26 at approximately 10:00 p.m. Subsequent measurements generally ranged from 153/102 to as high as 200/117 over the next several days until I saw Dr. on 1/31. Dr. prescribed Losartan 25mg daily. Took 1st dose on 1/31. Measurements have improved since 2nd dose of Losartan on 2/1, ranging from 121/73 to 163/96.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Impaired self-care
Clinical narrative: Unable to care for self.  Hospital Admission. This visit was more than 6 weeks after COVID vaccine.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Chills, Condition aggravated, Dyspnoea, Gait inability
Clinical narrative: At 6pm developed intense chills and muscle spasms, could not walk for 2 hours. Then she couldn't breath, so I gasped for a little while, then went to hospital and was admitted. Was treated with oxygen and a steroid. Hospitalized for 24 hr then released, spent another 10 days recovering with sore lungs (very bad asthma attacks)
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Pulmonary pain
Clinical narrative: At 6pm developed intense chills and muscle spasms, could not walk for 2 hours. Then she couldn't breath, so I gasped for a little while, then went to hospital and was admitted. Was treated with oxygen and a steroid. Hospitalized for 24 hr then released, spent another 10 days recovering with sore lungs (very bad asthma attacks)
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Urticaria
Clinical narrative: On the 15th I noticed a big red welt at my arm. Not at injection site. I had a couple on my back and one on my other arm. Monday morning, I had one on my foot that was really itchy. I figured it was a booster reaction. I contacted Primary Care and the provider prescribed topical steroid and Benadryl.  The 23rd my head was very itchy. I thought my family had lice so you treated everyone for lice Sunday evening  01/23/2022 I contacted my Dermatologist. I saw a PA and I cannot remember the name but I was prescribed Zyrtec OTC twice a day for 2 weeks and then once a week for remaining 6 weeks for 2 months total. She also prescribed prednisone if it has not got better.  The itching did get better but I am still covered in hives from head to toe.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Night sweats, Oral herpes, Pyrexia, Tremor
Clinical narrative: Fever spiking over 103 for almost three days, night sweats and serious shakes for two nights, fever blisters all over my mouth after day 2.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Clinician prepared vial with 1.3ml Normal Saline diluent rather than 1.8ml Normal Saline. No Clinical concerns were reported
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chills, Cough, Diarrhoea, Headache
Clinical narrative: @7AM 1/30/22 WOKE UP TO RASH ON HANDS, ARMS, NECK, BREASTS, STOMACH 1/31/22 CHILLS, SWEATS, NAUSEA, DIAREAH 2/1/22 CHILLS, SWAETS, NAUSEA, DIAREAH, COUGH, TIGHNESS IN CHEST, HEADACHE
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Nausea, Rash
Clinical narrative: @7AM 1/30/22 WOKE UP TO RASH ON HANDS, ARMS, NECK, BREASTS, STOMACH 1/31/22 CHILLS, SWEATS, NAUSEA, DIAREAH 2/1/22 CHILLS, SWAETS, NAUSEA, DIAREAH, COUGH, TIGHNESS IN CHEST, HEADACHE
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Hypoaesthesia, Induration, Neuralgia, Nodule
Clinical narrative: 01/31/2022 Noticed hard red knot and soreness around 7-8 pm.  On evening of 02/01/2022 soreness worsened and had a nerve type pain that shot down from neck to foot.  No improvement noted in knot.  On am of 02/02/2022 noted swelling of hand/fingers of left extremity and numbness also noted.   Patient reports taking ibuprofen, Tylenol and using warm compresses without relief.  Made an appointment with PCP today @ 1030am
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Peripheral swelling
Clinical narrative: 01/31/2022 Noticed hard red knot and soreness around 7-8 pm.  On evening of 02/01/2022 soreness worsened and had a nerve type pain that shot down from neck to foot.  No improvement noted in knot.  On am of 02/02/2022 noted swelling of hand/fingers of left extremity and numbness also noted.   Patient reports taking ibuprofen, Tylenol and using warm compresses without relief.  Made an appointment with PCP today @ 1030am
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Fibrin D dimer normal, Inflammation
Clinical narrative: chills, temp, fatigue inflammation of right arm with severe pain that radiates down the arm.  Has lasted over a week.  Medical treatment was sought. Doctor ordered Motrin and Ketorolac and also Tylenol with codeine ordered for pain.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: chills, temp, fatigue inflammation of right arm with severe pain that radiates down the arm.  Has lasted over a week.  Medical treatment was sought. Doctor ordered Motrin and Ketorolac and also Tylenol with codeine ordered for pain.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: It was discovered that the vaccine  received was stored in a freezer longer than recommended by the manufacturer.  Per the manufacturer, since the potency of the vaccine cannot be determined, it's unclear of the level of immunity this dose was expected to deliver.  After consulting with our immunization experts, and with the vaccine manufacturer, it's recommended to repeat the dose to ensure full protection.
Age: 66.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Chest pain, Small intestinal obstruction
Clinical narrative: ER - chest pain, ER - small bowel obstruction. Hospital admission. These visits were within 6 weeks of receiving the COVID vaccine.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Alanine aminotransferase normal, Angiogram pulmonary abnormal, Anticoagulant therapy, Aspartate aminotransferase increased
Clinical narrative: 73 year old gentleman with obesity, h/o stage III diffuse large B cell lymphoma s/p R-CHOP 4/2021 to 8/2021 (in remission), h/o H.pylori gastritis and BPH/LUTS who presented to ER on 1/10/22 with cough, shortness of breath and weakness of 2-3 days duration. Home COVID test was positive. Family noted desaturations on home pulse ox.   In ED, he was febrile to 103.5F, tachycardic and hypoxic to 80s on RA. COVID-19 swab was positive. Labs significant for LDH 478, ferritin 501, CRP 14, D dimer >4 and WBC 2.8K. CTA chest showed bilateral PE and ground glass consolidations. He was given Decadron, Remdesivir, Lovenox and admitted.    He had worsening hypoxic failure immediately after admission requiring oxymizer from 1/11/22 and then high flow oxygen from 1/14/22. He was given higher dose of Decadron and received Tocilizumab on 1/14 and 1/15/22.    Hospital course was also significant for possible superimposed bacterial PNA (Ceftriaxone 1/11-1/17, Doxycycline 1/11-1/22), S.epidermidis in blood culture 1/10 (Vanco 1/11-1/12, stopped as contaminant bacteria), possible fluid overload (BNP elevated 1/20, Lasix x 1), mild delirium and moderate PCM.    Hospitalization was prolonged due to his high oxygen needs.    o COVID-19 pneumonia, acute hypoxemic respiratory failure: Symptom onset on 1/7/22. COVID positive on 1/10/22. Last fever on 1/10/22. CRP decreased from 14 on 1/10 to 0.9 on 1/17/22.  - Weaned to 3-4 lpm nasal cannula now. Home oxygen arranged; goal SpO2 >92%. - He received Decadron 6mg on admission, 20mg daily from 1/11-1/17 then 10mg daily (1/18-1/22).  - He received Remdesivir course and Tocilizumab on 1/14 and 1/15.  - Continue isolation until 1/27/22 per Regional/Local ID guidance. - Follow up CXR in 4-6 weeks.  o Acute PE: He was on Lovenox 100mg sc bid and then switched to Pradaxa for 3 months duration.  o Moderate PCM: Intake has improved over last few days. Encourage intake. o H/o lymphoma, BPH/LUTS: Out-pt follow up advised. Out-patient CBC has been requested to monitor low WBC and platelets.    Primary Procedures:  CXR    Secondary Procedures: CTA chest
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood alkaline phosphatase normal, Blood bilirubin normal, Blood chloride normal, Blood creatinine normal
Clinical narrative: 73 year old gentleman with obesity, h/o stage III diffuse large B cell lymphoma s/p R-CHOP 4/2021 to 8/2021 (in remission), h/o H.pylori gastritis and BPH/LUTS who presented to ER on 1/10/22 with cough, shortness of breath and weakness of 2-3 days duration. Home COVID test was positive. Family noted desaturations on home pulse ox.   In ED, he was febrile to 103.5F, tachycardic and hypoxic to 80s on RA. COVID-19 swab was positive. Labs significant for LDH 478, ferritin 501, CRP 14, D dimer >4 and WBC 2.8K. CTA chest showed bilateral PE and ground glass consolidations. He was given Decadron, Remdesivir, Lovenox and admitted.    He had worsening hypoxic failure immediately after admission requiring oxymizer from 1/11/22 and then high flow oxygen from 1/14/22. He was given higher dose of Decadron and received Tocilizumab on 1/14 and 1/15/22.    Hospital course was also significant for possible superimposed bacterial PNA (Ceftriaxone 1/11-1/17, Doxycycline 1/11-1/22), S.epidermidis in blood culture 1/10 (Vanco 1/11-1/12, stopped as contaminant bacteria), possible fluid overload (BNP elevated 1/20, Lasix x 1), mild delirium and moderate PCM.    Hospitalization was prolonged due to his high oxygen needs.    o COVID-19 pneumonia, acute hypoxemic respiratory failure: Symptom onset on 1/7/22. COVID positive on 1/10/22. Last fever on 1/10/22. CRP decreased from 14 on 1/10 to 0.9 on 1/17/22.  - Weaned to 3-4 lpm nasal cannula now. Home oxygen arranged; goal SpO2 >92%. - He received Decadron 6mg on admission, 20mg daily from 1/11-1/17 then 10mg daily (1/18-1/22).  - He received Remdesivir course and Tocilizumab on 1/14 and 1/15.  - Continue isolation until 1/27/22 per Regional/Local ID guidance. - Follow up CXR in 4-6 weeks.  o Acute PE: He was on Lovenox 100mg sc bid and then switched to Pradaxa for 3 months duration.  o Moderate PCM: Intake has improved over last few days. Encourage intake. o H/o lymphoma, BPH/LUTS: Out-pt follow up advised. Out-patient CBC has been requested to monitor low WBC and platelets.    Primary Procedures:  CXR    Secondary Procedures: CTA chest
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Blood culture positive, Blood glucose normal, Blood lactate dehydrogenase increased, Blood lactic acid decreased, Blood potassium normal
Clinical narrative: 73 year old gentleman with obesity, h/o stage III diffuse large B cell lymphoma s/p R-CHOP 4/2021 to 8/2021 (in remission), h/o H.pylori gastritis and BPH/LUTS who presented to ER on 1/10/22 with cough, shortness of breath and weakness of 2-3 days duration. Home COVID test was positive. Family noted desaturations on home pulse ox.   In ED, he was febrile to 103.5F, tachycardic and hypoxic to 80s on RA. COVID-19 swab was positive. Labs significant for LDH 478, ferritin 501, CRP 14, D dimer >4 and WBC 2.8K. CTA chest showed bilateral PE and ground glass consolidations. He was given Decadron, Remdesivir, Lovenox and admitted.    He had worsening hypoxic failure immediately after admission requiring oxymizer from 1/11/22 and then high flow oxygen from 1/14/22. He was given higher dose of Decadron and received Tocilizumab on 1/14 and 1/15/22.    Hospital course was also significant for possible superimposed bacterial PNA (Ceftriaxone 1/11-1/17, Doxycycline 1/11-1/22), S.epidermidis in blood culture 1/10 (Vanco 1/11-1/12, stopped as contaminant bacteria), possible fluid overload (BNP elevated 1/20, Lasix x 1), mild delirium and moderate PCM.    Hospitalization was prolonged due to his high oxygen needs.    o COVID-19 pneumonia, acute hypoxemic respiratory failure: Symptom onset on 1/7/22. COVID positive on 1/10/22. Last fever on 1/10/22. CRP decreased from 14 on 1/10 to 0.9 on 1/17/22.  - Weaned to 3-4 lpm nasal cannula now. Home oxygen arranged; goal SpO2 >92%. - He received Decadron 6mg on admission, 20mg daily from 1/11-1/17 then 10mg daily (1/18-1/22).  - He received Remdesivir course and Tocilizumab on 1/14 and 1/15.  - Continue isolation until 1/27/22 per Regional/Local ID guidance. - Follow up CXR in 4-6 weeks.  o Acute PE: He was on Lovenox 100mg sc bid and then switched to Pradaxa for 3 months duration.  o Moderate PCM: Intake has improved over last few days. Encourage intake. o H/o lymphoma, BPH/LUTS: Out-pt follow up advised. Out-patient CBC has been requested to monitor low WBC and platelets.    Primary Procedures:  CXR    Secondary Procedures: CTA chest
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Blood sodium normal, Blood urea normal, Brain natriuretic peptide normal, C-reactive protein increased, COVID-19
Clinical narrative: 73 year old gentleman with obesity, h/o stage III diffuse large B cell lymphoma s/p R-CHOP 4/2021 to 8/2021 (in remission), h/o H.pylori gastritis and BPH/LUTS who presented to ER on 1/10/22 with cough, shortness of breath and weakness of 2-3 days duration. Home COVID test was positive. Family noted desaturations on home pulse ox.   In ED, he was febrile to 103.5F, tachycardic and hypoxic to 80s on RA. COVID-19 swab was positive. Labs significant for LDH 478, ferritin 501, CRP 14, D dimer >4 and WBC 2.8K. CTA chest showed bilateral PE and ground glass consolidations. He was given Decadron, Remdesivir, Lovenox and admitted.    He had worsening hypoxic failure immediately after admission requiring oxymizer from 1/11/22 and then high flow oxygen from 1/14/22. He was given higher dose of Decadron and received Tocilizumab on 1/14 and 1/15/22.    Hospital course was also significant for possible superimposed bacterial PNA (Ceftriaxone 1/11-1/17, Doxycycline 1/11-1/22), S.epidermidis in blood culture 1/10 (Vanco 1/11-1/12, stopped as contaminant bacteria), possible fluid overload (BNP elevated 1/20, Lasix x 1), mild delirium and moderate PCM.    Hospitalization was prolonged due to his high oxygen needs.    o COVID-19 pneumonia, acute hypoxemic respiratory failure: Symptom onset on 1/7/22. COVID positive on 1/10/22. Last fever on 1/10/22. CRP decreased from 14 on 1/10 to 0.9 on 1/17/22.  - Weaned to 3-4 lpm nasal cannula now. Home oxygen arranged; goal SpO2 >92%. - He received Decadron 6mg on admission, 20mg daily from 1/11-1/17 then 10mg daily (1/18-1/22).  - He received Remdesivir course and Tocilizumab on 1/14 and 1/15.  - Continue isolation until 1/27/22 per Regional/Local ID guidance. - Follow up CXR in 4-6 weeks.  o Acute PE: He was on Lovenox 100mg sc bid and then switched to Pradaxa for 3 months duration.  o Moderate PCM: Intake has improved over last few days. Encourage intake. o H/o lymphoma, BPH/LUTS: Out-pt follow up advised. Out-patient CBC has been requested to monitor low WBC and platelets.    Primary Procedures:  CXR    Secondary Procedures: CTA chest
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Carbon dioxide decreased, Chest X-ray abnormal, Coagulation test, Cough
Clinical narrative: 73 year old gentleman with obesity, h/o stage III diffuse large B cell lymphoma s/p R-CHOP 4/2021 to 8/2021 (in remission), h/o H.pylori gastritis and BPH/LUTS who presented to ER on 1/10/22 with cough, shortness of breath and weakness of 2-3 days duration. Home COVID test was positive. Family noted desaturations on home pulse ox.   In ED, he was febrile to 103.5F, tachycardic and hypoxic to 80s on RA. COVID-19 swab was positive. Labs significant for LDH 478, ferritin 501, CRP 14, D dimer >4 and WBC 2.8K. CTA chest showed bilateral PE and ground glass consolidations. He was given Decadron, Remdesivir, Lovenox and admitted.    He had worsening hypoxic failure immediately after admission requiring oxymizer from 1/11/22 and then high flow oxygen from 1/14/22. He was given higher dose of Decadron and received Tocilizumab on 1/14 and 1/15/22.    Hospital course was also significant for possible superimposed bacterial PNA (Ceftriaxone 1/11-1/17, Doxycycline 1/11-1/22), S.epidermidis in blood culture 1/10 (Vanco 1/11-1/12, stopped as contaminant bacteria), possible fluid overload (BNP elevated 1/20, Lasix x 1), mild delirium and moderate PCM.    Hospitalization was prolonged due to his high oxygen needs.    o COVID-19 pneumonia, acute hypoxemic respiratory failure: Symptom onset on 1/7/22. COVID positive on 1/10/22. Last fever on 1/10/22. CRP decreased from 14 on 1/10 to 0.9 on 1/17/22.  - Weaned to 3-4 lpm nasal cannula now. Home oxygen arranged; goal SpO2 >92%. - He received Decadron 6mg on admission, 20mg daily from 1/11-1/17 then 10mg daily (1/18-1/22).  - He received Remdesivir course and Tocilizumab on 1/14 and 1/15.  - Continue isolation until 1/27/22 per Regional/Local ID guidance. - Follow up CXR in 4-6 weeks.  o Acute PE: He was on Lovenox 100mg sc bid and then switched to Pradaxa for 3 months duration.  o Moderate PCM: Intake has improved over last few days. Encourage intake. o H/o lymphoma, BPH/LUTS: Out-pt follow up advised. Out-patient CBC has been requested to monitor low WBC and platelets.    Primary Procedures:  CXR    Secondary Procedures: CTA chest
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Delirium, Dyspnoea, Electrocardiogram abnormal, Eosinophil percentage decreased, Fibrin D dimer
Clinical narrative: 73 year old gentleman with obesity, h/o stage III diffuse large B cell lymphoma s/p R-CHOP 4/2021 to 8/2021 (in remission), h/o H.pylori gastritis and BPH/LUTS who presented to ER on 1/10/22 with cough, shortness of breath and weakness of 2-3 days duration. Home COVID test was positive. Family noted desaturations on home pulse ox.   In ED, he was febrile to 103.5F, tachycardic and hypoxic to 80s on RA. COVID-19 swab was positive. Labs significant for LDH 478, ferritin 501, CRP 14, D dimer >4 and WBC 2.8K. CTA chest showed bilateral PE and ground glass consolidations. He was given Decadron, Remdesivir, Lovenox and admitted.    He had worsening hypoxic failure immediately after admission requiring oxymizer from 1/11/22 and then high flow oxygen from 1/14/22. He was given higher dose of Decadron and received Tocilizumab on 1/14 and 1/15/22.    Hospital course was also significant for possible superimposed bacterial PNA (Ceftriaxone 1/11-1/17, Doxycycline 1/11-1/22), S.epidermidis in blood culture 1/10 (Vanco 1/11-1/12, stopped as contaminant bacteria), possible fluid overload (BNP elevated 1/20, Lasix x 1), mild delirium and moderate PCM.    Hospitalization was prolonged due to his high oxygen needs.    o COVID-19 pneumonia, acute hypoxemic respiratory failure: Symptom onset on 1/7/22. COVID positive on 1/10/22. Last fever on 1/10/22. CRP decreased from 14 on 1/10 to 0.9 on 1/17/22.  - Weaned to 3-4 lpm nasal cannula now. Home oxygen arranged; goal SpO2 >92%. - He received Decadron 6mg on admission, 20mg daily from 1/11-1/17 then 10mg daily (1/18-1/22).  - He received Remdesivir course and Tocilizumab on 1/14 and 1/15.  - Continue isolation until 1/27/22 per Regional/Local ID guidance. - Follow up CXR in 4-6 weeks.  o Acute PE: He was on Lovenox 100mg sc bid and then switched to Pradaxa for 3 months duration.  o Moderate PCM: Intake has improved over last few days. Encourage intake. o H/o lymphoma, BPH/LUTS: Out-pt follow up advised. Out-patient CBC has been requested to monitor low WBC and platelets.    Primary Procedures:  CXR    Secondary Procedures: CTA chest
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Full blood count, Glycosylated haemoglobin increased, Haematocrit increased, Haemoglobin decreased, Hepatic cyst
Clinical narrative: 73 year old gentleman with obesity, h/o stage III diffuse large B cell lymphoma s/p R-CHOP 4/2021 to 8/2021 (in remission), h/o H.pylori gastritis and BPH/LUTS who presented to ER on 1/10/22 with cough, shortness of breath and weakness of 2-3 days duration. Home COVID test was positive. Family noted desaturations on home pulse ox.   In ED, he was febrile to 103.5F, tachycardic and hypoxic to 80s on RA. COVID-19 swab was positive. Labs significant for LDH 478, ferritin 501, CRP 14, D dimer >4 and WBC 2.8K. CTA chest showed bilateral PE and ground glass consolidations. He was given Decadron, Remdesivir, Lovenox and admitted.    He had worsening hypoxic failure immediately after admission requiring oxymizer from 1/11/22 and then high flow oxygen from 1/14/22. He was given higher dose of Decadron and received Tocilizumab on 1/14 and 1/15/22.    Hospital course was also significant for possible superimposed bacterial PNA (Ceftriaxone 1/11-1/17, Doxycycline 1/11-1/22), S.epidermidis in blood culture 1/10 (Vanco 1/11-1/12, stopped as contaminant bacteria), possible fluid overload (BNP elevated 1/20, Lasix x 1), mild delirium and moderate PCM.    Hospitalization was prolonged due to his high oxygen needs.    o COVID-19 pneumonia, acute hypoxemic respiratory failure: Symptom onset on 1/7/22. COVID positive on 1/10/22. Last fever on 1/10/22. CRP decreased from 14 on 1/10 to 0.9 on 1/17/22.  - Weaned to 3-4 lpm nasal cannula now. Home oxygen arranged; goal SpO2 >92%. - He received Decadron 6mg on admission, 20mg daily from 1/11-1/17 then 10mg daily (1/18-1/22).  - He received Remdesivir course and Tocilizumab on 1/14 and 1/15.  - Continue isolation until 1/27/22 per Regional/Local ID guidance. - Follow up CXR in 4-6 weeks.  o Acute PE: He was on Lovenox 100mg sc bid and then switched to Pradaxa for 3 months duration.  o Moderate PCM: Intake has improved over last few days. Encourage intake. o H/o lymphoma, BPH/LUTS: Out-pt follow up advised. Out-patient CBC has been requested to monitor low WBC and platelets.    Primary Procedures:  CXR    Secondary Procedures: CTA chest
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Hepatitis B core antibody negative, Hepatitis B surface antibody negative, Hepatitis B surface antigen negative, Hepatitis C antibody negative, Hiatus hernia
Clinical narrative: 73 year old gentleman with obesity, h/o stage III diffuse large B cell lymphoma s/p R-CHOP 4/2021 to 8/2021 (in remission), h/o H.pylori gastritis and BPH/LUTS who presented to ER on 1/10/22 with cough, shortness of breath and weakness of 2-3 days duration. Home COVID test was positive. Family noted desaturations on home pulse ox.   In ED, he was febrile to 103.5F, tachycardic and hypoxic to 80s on RA. COVID-19 swab was positive. Labs significant for LDH 478, ferritin 501, CRP 14, D dimer >4 and WBC 2.8K. CTA chest showed bilateral PE and ground glass consolidations. He was given Decadron, Remdesivir, Lovenox and admitted.    He had worsening hypoxic failure immediately after admission requiring oxymizer from 1/11/22 and then high flow oxygen from 1/14/22. He was given higher dose of Decadron and received Tocilizumab on 1/14 and 1/15/22.    Hospital course was also significant for possible superimposed bacterial PNA (Ceftriaxone 1/11-1/17, Doxycycline 1/11-1/22), S.epidermidis in blood culture 1/10 (Vanco 1/11-1/12, stopped as contaminant bacteria), possible fluid overload (BNP elevated 1/20, Lasix x 1), mild delirium and moderate PCM.    Hospitalization was prolonged due to his high oxygen needs.    o COVID-19 pneumonia, acute hypoxemic respiratory failure: Symptom onset on 1/7/22. COVID positive on 1/10/22. Last fever on 1/10/22. CRP decreased from 14 on 1/10 to 0.9 on 1/17/22.  - Weaned to 3-4 lpm nasal cannula now. Home oxygen arranged; goal SpO2 >92%. - He received Decadron 6mg on admission, 20mg daily from 1/11-1/17 then 10mg daily (1/18-1/22).  - He received Remdesivir course and Tocilizumab on 1/14 and 1/15.  - Continue isolation until 1/27/22 per Regional/Local ID guidance. - Follow up CXR in 4-6 weeks.  o Acute PE: He was on Lovenox 100mg sc bid and then switched to Pradaxa for 3 months duration.  o Moderate PCM: Intake has improved over last few days. Encourage intake. o H/o lymphoma, BPH/LUTS: Out-pt follow up advised. Out-patient CBC has been requested to monitor low WBC and platelets.    Primary Procedures:  CXR    Secondary Procedures: CTA chest
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, International normalised ratio increased, Lipase normal, Liver function test, Lung consolidation
Clinical narrative: 73 year old gentleman with obesity, h/o stage III diffuse large B cell lymphoma s/p R-CHOP 4/2021 to 8/2021 (in remission), h/o H.pylori gastritis and BPH/LUTS who presented to ER on 1/10/22 with cough, shortness of breath and weakness of 2-3 days duration. Home COVID test was positive. Family noted desaturations on home pulse ox.   In ED, he was febrile to 103.5F, tachycardic and hypoxic to 80s on RA. COVID-19 swab was positive. Labs significant for LDH 478, ferritin 501, CRP 14, D dimer >4 and WBC 2.8K. CTA chest showed bilateral PE and ground glass consolidations. He was given Decadron, Remdesivir, Lovenox and admitted.    He had worsening hypoxic failure immediately after admission requiring oxymizer from 1/11/22 and then high flow oxygen from 1/14/22. He was given higher dose of Decadron and received Tocilizumab on 1/14 and 1/15/22.    Hospital course was also significant for possible superimposed bacterial PNA (Ceftriaxone 1/11-1/17, Doxycycline 1/11-1/22), S.epidermidis in blood culture 1/10 (Vanco 1/11-1/12, stopped as contaminant bacteria), possible fluid overload (BNP elevated 1/20, Lasix x 1), mild delirium and moderate PCM.    Hospitalization was prolonged due to his high oxygen needs.    o COVID-19 pneumonia, acute hypoxemic respiratory failure: Symptom onset on 1/7/22. COVID positive on 1/10/22. Last fever on 1/10/22. CRP decreased from 14 on 1/10 to 0.9 on 1/17/22.  - Weaned to 3-4 lpm nasal cannula now. Home oxygen arranged; goal SpO2 >92%. - He received Decadron 6mg on admission, 20mg daily from 1/11-1/17 then 10mg daily (1/18-1/22).  - He received Remdesivir course and Tocilizumab on 1/14 and 1/15.  - Continue isolation until 1/27/22 per Regional/Local ID guidance. - Follow up CXR in 4-6 weeks.  o Acute PE: He was on Lovenox 100mg sc bid and then switched to Pradaxa for 3 months duration.  o Moderate PCM: Intake has improved over last few days. Encourage intake. o H/o lymphoma, BPH/LUTS: Out-pt follow up advised. Out-patient CBC has been requested to monitor low WBC and platelets.    Primary Procedures:  CXR    Secondary Procedures: CTA chest
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Lung opacity, Lymphocyte percentage, Mean cell volume normal, Monocyte percentage increased, Myelopathy
Clinical narrative: 73 year old gentleman with obesity, h/o stage III diffuse large B cell lymphoma s/p R-CHOP 4/2021 to 8/2021 (in remission), h/o H.pylori gastritis and BPH/LUTS who presented to ER on 1/10/22 with cough, shortness of breath and weakness of 2-3 days duration. Home COVID test was positive. Family noted desaturations on home pulse ox.   In ED, he was febrile to 103.5F, tachycardic and hypoxic to 80s on RA. COVID-19 swab was positive. Labs significant for LDH 478, ferritin 501, CRP 14, D dimer >4 and WBC 2.8K. CTA chest showed bilateral PE and ground glass consolidations. He was given Decadron, Remdesivir, Lovenox and admitted.    He had worsening hypoxic failure immediately after admission requiring oxymizer from 1/11/22 and then high flow oxygen from 1/14/22. He was given higher dose of Decadron and received Tocilizumab on 1/14 and 1/15/22.    Hospital course was also significant for possible superimposed bacterial PNA (Ceftriaxone 1/11-1/17, Doxycycline 1/11-1/22), S.epidermidis in blood culture 1/10 (Vanco 1/11-1/12, stopped as contaminant bacteria), possible fluid overload (BNP elevated 1/20, Lasix x 1), mild delirium and moderate PCM.    Hospitalization was prolonged due to his high oxygen needs.    o COVID-19 pneumonia, acute hypoxemic respiratory failure: Symptom onset on 1/7/22. COVID positive on 1/10/22. Last fever on 1/10/22. CRP decreased from 14 on 1/10 to 0.9 on 1/17/22.  - Weaned to 3-4 lpm nasal cannula now. Home oxygen arranged; goal SpO2 >92%. - He received Decadron 6mg on admission, 20mg daily from 1/11-1/17 then 10mg daily (1/18-1/22).  - He received Remdesivir course and Tocilizumab on 1/14 and 1/15.  - Continue isolation until 1/27/22 per Regional/Local ID guidance. - Follow up CXR in 4-6 weeks.  o Acute PE: He was on Lovenox 100mg sc bid and then switched to Pradaxa for 3 months duration.  o Moderate PCM: Intake has improved over last few days. Encourage intake. o H/o lymphoma, BPH/LUTS: Out-pt follow up advised. Out-patient CBC has been requested to monitor low WBC and platelets.    Primary Procedures:  CXR    Secondary Procedures: CTA chest
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Neutrophil percentage, Oxygen saturation decreased, Platelet count normal, Pleural effusion, Prothrombin time prolonged
Clinical narrative: 73 year old gentleman with obesity, h/o stage III diffuse large B cell lymphoma s/p R-CHOP 4/2021 to 8/2021 (in remission), h/o H.pylori gastritis and BPH/LUTS who presented to ER on 1/10/22 with cough, shortness of breath and weakness of 2-3 days duration. Home COVID test was positive. Family noted desaturations on home pulse ox.   In ED, he was febrile to 103.5F, tachycardic and hypoxic to 80s on RA. COVID-19 swab was positive. Labs significant for LDH 478, ferritin 501, CRP 14, D dimer >4 and WBC 2.8K. CTA chest showed bilateral PE and ground glass consolidations. He was given Decadron, Remdesivir, Lovenox and admitted.    He had worsening hypoxic failure immediately after admission requiring oxymizer from 1/11/22 and then high flow oxygen from 1/14/22. He was given higher dose of Decadron and received Tocilizumab on 1/14 and 1/15/22.    Hospital course was also significant for possible superimposed bacterial PNA (Ceftriaxone 1/11-1/17, Doxycycline 1/11-1/22), S.epidermidis in blood culture 1/10 (Vanco 1/11-1/12, stopped as contaminant bacteria), possible fluid overload (BNP elevated 1/20, Lasix x 1), mild delirium and moderate PCM.    Hospitalization was prolonged due to his high oxygen needs.    o COVID-19 pneumonia, acute hypoxemic respiratory failure: Symptom onset on 1/7/22. COVID positive on 1/10/22. Last fever on 1/10/22. CRP decreased from 14 on 1/10 to 0.9 on 1/17/22.  - Weaned to 3-4 lpm nasal cannula now. Home oxygen arranged; goal SpO2 >92%. - He received Decadron 6mg on admission, 20mg daily from 1/11-1/17 then 10mg daily (1/18-1/22).  - He received Remdesivir course and Tocilizumab on 1/14 and 1/15.  - Continue isolation until 1/27/22 per Regional/Local ID guidance. - Follow up CXR in 4-6 weeks.  o Acute PE: He was on Lovenox 100mg sc bid and then switched to Pradaxa for 3 months duration.  o Moderate PCM: Intake has improved over last few days. Encourage intake. o H/o lymphoma, BPH/LUTS: Out-pt follow up advised. Out-patient CBC has been requested to monitor low WBC and platelets.    Primary Procedures:  CXR    Secondary Procedures: CTA chest